These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2479847)

  • 1. [Analysis of the water-soluble protein fraction of glioma cells by two-dimensional electrophoresis].
    Honda C; Tabuchi K; Nishimoto A
    Neurol Med Chir (Tokyo); 1989 Jun; 29(6):465-70. PubMed ID: 2479847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identity of the proliferating cell nuclear antigen and cyclin.
    Mathews MB; Bernstein RM; Franza BR; Garrels JI
    Nature; 1984 May 24-30; 309(5966):374-6. PubMed ID: 6145097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gel electrophoretic analysis of nuclear matrix fractions isolated from different human cell lines.
    Kallajoki M; Osborn M
    Electrophoresis; 1994; 15(3-4):520-8. PubMed ID: 8055879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative flow cytometric analysis of proliferating cell nuclear antigen (PCNA) antibodies in human solid neoplasms.
    Teague K; el-Naggar A
    Cytometry; 1994 Jan; 15(1):21-7. PubMed ID: 7909288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical expression of proliferating cell nuclear antigen (PCNA) in intracranial glioma and meningioma.
    Shih YH; Kadota Y; Sato K; Sueyoshi N; Shirai T
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Apr; 53(4):193-7. PubMed ID: 7911730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferating cell nuclear antigen immunostaining in breast cancer and its relation to prognosis.
    Narita T; Funahashi H; Satoh Y; Takagi H
    Jpn J Clin Oncol; 1993 Feb; 23(1):20-5. PubMed ID: 8096256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytochemical detection of cell proliferation-related antigens in cytologic smears of human malignant neoplasms using PC10, reactive with proliferating cell nuclear antigen, and Ki-67. A comparative study.
    Pelosi G; Bresaola E; Manfrin E; Rodella S; Schiavon I; Iannucci A
    Arch Pathol Lab Med; 1994 May; 118(5):510-6. PubMed ID: 7910728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of proliferating cell nuclear antigen (PCNA/cyclin) in glioma cells.
    Tabuchi K; Honda C; Nakane PK
    Neurol Med Chir (Tokyo); 1987 Jan; 27(1):1-5. PubMed ID: 2441281
    [No Abstract]   [Full Text] [Related]  

  • 9. Proliferating cell nuclear antigen expression in rat glioma model: comparison with bromodeoxyuridine labeling index.
    Nakasu S; Nakajima M; Nioka H; Matsumura K; Handa J
    Neurol Med Chir (Tokyo); 1994 May; 34(5):269-73. PubMed ID: 7519746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear and DNA-binding proteins in human brain tumors.
    Müller A; Henn W; Unteregger G
    Electrophoresis; 1991; 12(7-8):515-23. PubMed ID: 1915244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell proliferation of transitional cell bladder cancer determined by PCNA/cyclin immunostaining. A histopathological description.
    Lipponen PK; Eskelinen MJ
    Anticancer Res; 1992; 12(2):577-83. PubMed ID: 1349799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrastructural localization and fluctuation in the level of the proliferating cell nuclear antigen and myc oncoproteins in synchronized neuroblastoma cells.
    Gazitt Y; Erdos GW; Cohen RJ
    Cancer Res; 1993 Apr; 53(8):1899-905. PubMed ID: 8096797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas.
    Pich A; Ponti R; Valente G; Chiusa L; Geuna M; Novero D; Palestro G
    J Clin Pathol; 1994 Jan; 47(1):18-22. PubMed ID: 7907607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative flow cytometric analysis of Ki-67 and proliferating cell nuclear antigen (PCNA) in solid neoplasms.
    Steck K; el-Naggar AK
    Cytometry; 1994 Nov; 17(3):258-65. PubMed ID: 7851161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of proliferating cell nuclear antigen in hepatocellular carcinoma.
    Wu JD; Tseng HH
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Apr; 53(4):198-203. PubMed ID: 7911731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PCNA/cyclin expression and BrdU uptake define different subpopulations in different cell lines.
    Coltrera MD; Gown AM
    J Histochem Cytochem; 1991 Jan; 39(1):23-30. PubMed ID: 1670579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of immunohistochemical staining of proliferating cells in paraffin sections of breast carcinoma using antibodies to proliferating cell nuclear antigen and the Ki-67 antigen.
    Yu CC; Dublin EA; Camplejohn RS; Levison DA
    Anal Cell Pathol; 1995 Jul; 9(1):45-52. PubMed ID: 7577754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell proliferation of transitional cell bladder tumours determined by PCNA/cyclin immunostaining and its prognostic value.
    Lipponen PK; Eskelinen MJ
    Br J Cancer; 1992 Jul; 66(1):171-6. PubMed ID: 1353364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical evidence for the expression of proliferating cell nuclear antigen (PCNA) by non-proliferating hepatocytes adjacent to metastatic tumours and in inflammatory conditions.
    Harrison RF; Reynolds GM; Rowlands DC
    J Pathol; 1993 Oct; 171(2):115-22. PubMed ID: 7904308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between PCNA and AgNOR scores in non-Hodgkin's lymphomas using sequential staining technique.
    Smith FG; Murray PG; Crocker J
    J Clin Pathol; 1993 Jan; 46(1):28-31. PubMed ID: 8094401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.